• Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
    with Jack Taunton, I. M. Serafimova, M. A. Pufall, K. Duda, M. S. Cohen, R. L. Maglathlin, J. M. McFarland, R. M. Miller, and M. Frödin
    Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacological potency and selectivity. Nevertheless, concerns about off-target modification motivate the development of reversible.